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Conclusion. Damage to TBM develops in acute rejection asAcute rejection-associated tubular basement membrane changes
a consequence of interstitial inflammation and tubulitis. Theseand chronic allograft nephropathy.
lytic events correlate with the later development of clinical andBackground. Acute rejection is a major risk factor for chronic
morphologic evidence of chronic injury in the absence of arterialallograft nephropathy, although the link(s) between these events
injury of chronic rejection. We suggest that chronic allograftis not understood. The hypothesis of this study is that alter-
nephropathy may have an inflammatory interstitial origin.ations in tubular basement membranes (TBMs) that occur dur-
ing acute rejection may be irreversible and thereby play a role
in the development of chronic allograft nephropathy.
Methods. Fourteen renal transplant patients were selected,
Chronic rejection (CR) is the most common cause ofeach having had two or more biopsies performed (42 total).
late-developing graft loss. The conventional view holdsAll biopsies were scored for acute and chronic rejection using
Banff 1997 criteria. The initial biopsy showed only acute inter- that CR has a vascular etiology [1–5]. Recently, attention
stitial rejection (type I rejection). No biopsies contained sig- has been directed toward interstitial contributions since
nificant chronic arterial lesions of chronic vascular rejection. one of the strongest predictors of late graft failures isThe entire cortex was examined on Jones methenamine silver-
the timing, number, and severity of acute rejection (AR)stained sections at 3400 for interruption in TBM staining. The
episodes [5–12]. Even the presence of subclinical rejec-number of tubules with TBM abnormalities was counted, and
the renal cortical area was measured by image analysis. Periodic tion in early protocol biopsies, defined as the presence of
acid-Schiff/immunoperoxidase stain was performed on 12 acute “borderline rejection” (“Banff 95”), has been associated
rejection biopsies stained for laminin, cytokeratin 7, CD3, CD20,
with elevated creatinine at one year compared with biop-and CD68. Controls consisted of 11 biopsies (8 negative for
sies free of all infiltrates [13–15]. The postulate of thisrejection and 3 acute tubular necrosis).
Results. Numerous TBM alterations in silver staining were investigation is that a threshold of tubular epithelial cell
identified as being associated with acute rejection and tubulitis, injury exists, which if exceeded, leads to irreversible tubu-
consisting of abrupt TBM discontinuities and/or extreme atten- lar damage that could culminate in eventual loss of the
uation with segmental or complete absence of TBM. A loss of
entire nephron, despite successful reversal of the AR. ThisTBM matrix proteins was confirmed by absent laminin staining
chronic damage would manifest in later biopsies as thein areas of acute rejection and tubulitis. There was herniation
of tubular cells into the interstitium through TBM defects con- nonspecific lesion chronic allograft nephropathy (CAN),
firmed by cytokeratin staining. The TBM defects were spatially but would actually represent chronic interstitial rejection.
associated with inflammatory cells, particularly macrophages. Disruption of tubular basement membranes (TBMs) was
When the biopsies were divided into two groups, ,10 and .10
targeted as a possible threshold injury because of theTBM breaks/mm2, there were statistically significant morpho-
importance of an intact basement membrane (BM) scaf-logic and clinical correlations. The number of TBM disruptions
correlated with the serum creatinine at the time of biopsy, a folding in regeneration following an acute insult [16, 17].
combined Banff t 1 i score, the difference in tubular atrophy
between the initial and most recent biopsy and the difference
between the nadir creatinine and most recent creatinine. METHODS
Fourteen patients having two or more renal transplant
biopsies (total biopsies 5 42) at least six or more weeksKey words: kidney graft rejection, tubulitis, interstitial inflammation,
basement membrane, biopsy. apart (an average of 8.5 6 1.8 months) and 11 control
biopsies (8 normal and 3 acute tubular necrosis) wereReceived for publication February 24, 2000
studied. The biopsies were performed from 2 to 28 weeksand in revised form April 28, 2000
Accepted for publication June 5, 2000 (an average of 7.4 weeks) post-transplant. Patient selec-
tion was based on the presence of acute tubulointerstitialÓ 2000 by the International Society of Nephrology
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Table 1. Source of antibodies, dilution and reaction conditions RESULTS
Reagent Source Dilution Enzyme/Ag retrieval The total number of tubules with TBM breaks in the
Cytokeratin 7 DAKO Prediluted Proteinase-K 3 min first AR biopsies ranged from 7 to 103 breaks per biopsy
Laminin DAKO 1:50 Proteinase-K 3 min (Table 2). The TBM breaks usually consisted of short
CD3 DAKO Prediluted Steam 20 min
segments of absent staining invariably associated withCD20 DAKO Prediluted None
CD68 DAKO Prediluted Steam 20 min foci of acute interstitial rejection and tubulitis. The TBM
breaks ranged from abrupt termination of TBM staining
with distinct boundaries to segments of gradual attenua-
tion of staining until no staining was visible (Fig. 1).
rejection (Banff 97 and NIH/CCTT type 1 rejection) Some tubules showed no silver staining of the TBM (Fig.
in the first biopsy [18, 19]. No biopsy showed arterial 2). Infrequently, herniation of tubular epithelial cells
alterations of chronic vascular rejection [18, 19]. A com- through the TBM breaks and into the inflamed intersti-
bined AR score was generated consisting of the sum tium was observed (Fig. 3). Repair of the damaged tu-
of the tubulitis (“t”) and interstitial inflammation (“i”) bules was also observed within the acutely inflamed tu-
scores using the “Banff 97” criteria [19]. bules. This included mitotic activity of tubular epithelial
All patient medical records were reviewed for age cells and formation of new basement membrane in foci
at transplant, gender, race, transplant number (first or of tubulitis and TBM disruption (Fig. 4).
second), human lymphocyte antigen mismatches, induc- In foci of intense interstitial inflammation in every
tion therapy, maintenance immunosuppression therapy, case, individual cells or small clusters of cells with large
need for dialysis post-transplant, nadir serum creatinine pale nuclei were observed that had nuclear features simi-
prior to the first rejection episode, serum creatinine at lar to the adjacent tubular epithelial cells (Fig. 5). These
the time of biopsy, cytomegalovirus (CMV) antigenemia were not separately quantitated. Qualitatively, they var-
at the time of biopsy, and most recent serum creatinine. ied from an occasional finding to numerous. Since no
To ensure a single detection threshold, two authors
tubular lumen or silver TBM staining was observed to
(S.M.B. and P.D.W.) counted the number of cortical
support tubular origin, a PAS/IP stain for CK 7 (stainsTBM breaks by examining the entire biopsy core stained
distal tubules) was performed to identify epithelial cellwith Jones methenamine silver at 3400 magnification. A
lineage. Cells within the inflamed interstitium withoutTBM break was defined as a segment of interrupted silver
discernible PAS-positive TBM stained for CK 7, support-staining of the TBM. Tubular atrophy was quantitated on
ing an epithelial origin. Some cells appeared separatethe initial and most recent biopsies by counting the num-
from tubules, possibly no longer physically connected tober of tubules with a thickened and/or replicated TBM
their tubule of origin (Fig. 6). Other cell clusters wereon silver-stained sections. A periodic acid-Schiff (PAS)/
connected by slender strands of cytokeratin-positive cy-immunoperoxidase (IP) stain was developed to stain T
toplasm, suggesting that they were derived from thatcells (CD3), B cells (CD20), macrophages (CD68), cyto-
tubule (Fig. 7).keratin 7 (CK 7), and laminin. The antibody source,
To confirm that TBM interruptions observed by silverdilution, and reaction conditions are listed in Table 1.
staining methods actually reflected an absence of TBMThe stains consisted of sequential staining, first with a
components, a PAS/IP stain for laminin was performedconventional periodic acid-Schiff stain and followed by a
in 12 biopsies of varying severity of rejection. TBMroutine immunoperoxidase technique using a Dako immu-
breaks were not quantitated; however, foci of inter-nostainer (Carpinteria, CA, USA).
rupted laminin staining were clearly observed in the ar-
Image analysis eas of most intense inflammation, indicating a loss of at
least one TBM matrix protein (Fig. 8).Slide images were generated using a Nikon E800 mi-
The immunophenotype of the inflammatory compo-croscope fitted with an Optronics EDI 750 digital camera
nent in AR and their relationship to the TBM werelinked to a Macintosh 8600 computer. An image of each
evaluated by PAS/IP stains for T cells, B cells, and mac-biopsy was captured “in toto,” and the biopsy area was
rophages in 12 biopsies. There were 1476 tubules withdetermined using Scion image (Scion Corp., Fredrick,
tubulitis that contained 5154 T cells, 593 macrophages,MD, USA).
and 12 B cells. Macrophages were concentrated within
Statistical analysis the interstitium and were often observed to be flattened
against the TBM. They were particularly numerous inAll measured values are reported as mean 6 SEM. The
the area of TBM disruption.groups were compared using analysis of variance with
Chronic features such as tubular atrophy and fibro-Scheffe post hoc using Statview (Abacus Concepts, Berke-
intimal arterial thickening were quantitated in the initialley, CA, USA) on a Macintosh 8600 computer. Statistical
significance was considered with a P value ,0.05. and most recent biopsies. Atrophic tubules had thick-
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Table 2. Morphologic and clinical data
t 1 i Months TBM Atrophy/ Months Creatinine Creatinine Follow-up
Case # score to 1st Bx breaks/mm2 mm2 to 2nd Bx nadir final months
1 1 1.5 0.9 10.6 8 1.3 2.0 40
2 2 1.0 1.7 41.0 5 0.7 1.7 25
3 5 1.5 2.4 14.2 25 1.4 1.4 46
4 1 0.5 2.9 2.8 4 0.8 1.2 30
5 2 0.25 6.2 5.3 1.5 1.1 2.6 30
6 3 0.5 7.8 18.8 5 0.9 1.5 13
7 4 7.75 9.3 8.2 8 1.2 3.0 35
8 5 11.0 11.0 9.7 19 1.1 12.0 25
9 3 1.0 20.0 25.4 11 1.2 8.0 23
10 3 0.5 21.9 12.9 11 1.6 3.2 26
11 6 0.5 22.0 47.2 20 1.2 12.0 26
12 5 0.75 22.2 96.4 32 1.5 5.0 38
13 6 3.0 34.7 33.7 14 1.2 1.9 43
14 6 0.5 51.9 51.0 8 1.0 1.9 36
Abbreviations are: t 1 i, tubulitis 1 interstitial inflammation; Bx, biopsy; TBM, tubular basement membrane;
Fig. 1. Segmental disruption of tubular basement membrane (TBM; Fig. 2. A tubule (T) with nearly complete loss of visible TBM.
arrow) in an area of acute rejection (AR)-associated tubulitis.
ent in the 14 initial biopsies. In the most recent biopsies,ened and often replicated TBM. The initial biopsies con-
only 2 out of 29 intralobular and arcuate arteries hadtained few atrophic tubules, 0.00 to 3.47/mm2. The num-
11 intimal thickening (,25% luminal compromise); 27ber was higher in the most recent biopsy in 13 out of 14
arteries were free of intimal lesions. No biopsy containedcases and ranged from 2.83 to 96.43/mm2. No chronic
glomerular evidence of CR in the form of chronic trans-arterial lesions in the form of intimal thickening were
identified in the 27 intralobular and arcuate arteries pres- plant glomerulopathy.
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Fig. 3. Focal TBM disruption with herniation of epithelial cells into
Fig. 4. Focal TBM disruption with herniation of epithelial cells intothe inflamed interstitium (arrow).
the interstitium associated with a cell in mitosis and evidence of new
basement membrane formation (replication of TBM).
The 11 control biopsies [8 normal and 3 acute tubular
necrosis (ATN)] were examined. The negative biopsies
in group 1 and 3.1 (range 1 to 4) in group 2. Induction
were performed early in the post-transplant period (2 to
therapy was similar and about equally split between anti-
28 weeks, an average of 7.4 weeks). They contained from
thymocyte globulin and OKT-3 regimens. One patient0.00 to 2.91 breaks/mm2 (an average of 0.747). The three
received cyclosporine induction (group 2). Maintenancecases of ATN representing primary nonfunction had
immunosuppression was Cellcept or FK506. Three pa-0.29, 3.15, and 9.82 breaks/mm2, respectively.
tients from each group were seropositive, and four fromThe patients were divided into two groups: those with
each group were seronegative for CMV at the time of,10 breaks/mm2 and those with .10 breaks/mm2. The
rejection. Statistical analysis of the clinical parametersclinical parameters were almost equally divided between
revealed no differences between the two groups.the two groups. In all patients, the transplant was their
The difference in the number of TBM breaks betweenfirst. The mean ages were 45.2 years (range 31 to 57)
the two groups at the initial biopsy strongly predictedand 36.5 years (range 13 to 52), and there were four
both poorer renal function and the development of moremales and three females in the ,10 group and five males
tubular atrophy (Table 3 and Fig. 9). The number ofand two females in the .10 group. The race breakdown
TBM break/mm2 correlated with the difference in serumwas four Caucasians and three African Americans in the
creatinine at time of biopsy and the lowest creatininefirst group and five Caucasians and two African Ameri-
post-transplant and the combined t 1 i score (Table 2).cans in the second group. There were three cadaveric
More significantly, the number of TBM breaks/mm2 ontransplants and four living related-donor transplants in
the initial biopsy correlated with the difference betweenthe ,10 TBM breaks group and four cadaveric trans-
the final serum creatinine and the nadir post-transplant/plants and three living related-donor transplants in the
month, and the difference in TA/mm2/month between.10 TBM breaks group. The mean number of human
lymphocyte anitgen mismatches was 3.4 (range 0 to 6) the initial and the final biopsy.
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phage infiltrates within the intima of large arteries [3, 20].
However, large clinical studies with biopsy correlation
have identified AR as the most powerful predictor of
CR [6–12]. Although severe, multiple, late developing,
and prolonged episodes of AR are most predictive of
chronic injury, even mild episodes appear important.
Subclinical rejection (defined as “borderline rejection”
in “Banff 93”) in early protocol biopsies has also been
associated with elevated creatinine at one year compared
with biopsies free of all infiltrates [13, 14].
The cellular and molecular events responsible for the
association between AR and CR are not known. How-
ever, once chronic changes are identified on the biopsy,
a progressive course becomes likely. This has been shown
in protocol biopsies performed at six months in which
the presence of tubular atrophy (TA) and interstitial fi-
brosis (IF) strongly predicted the development of CAN
[21, 22]. The etiology(s) of the TA and IF in the six-month
biopsies is unclear, but did not appear to be linked to
large arterial disease because the biopsies lacked chronic
vascular abnormalities. Identification of the mechanistic
link between AR and chronic damage unrelated to occlu-
sive arterial disease is crucial for the design of strategies
to prevent CAN. Since AR is an inflammatory process
centered on tubules and the adjacent interstitial struc-
tures, investigation of alterations in these regions is a
logical approach. Two unique alterations in peritubular
capillaries (PTCs) have been identified that appear spe-
cific for type II AR and CR, respectively. PTC depositionFig. 5. Cells within this focus of severe AR have large nuclei (arrow)
similar to those of adjacent tubules. of C4d has been shown to strongly correlate with hu-
moral mechanisms in AR [23]. Reduplication or a multi-
layering of the PTC basement membrane has been
strongly associated with CR and chronic transplant glo-
DISCUSSION merulopathy [24–26]. These two PTC alterations may
themselves ultimately be linked causally, since both rep-The last decade has witnessed significant improvement
resent putative endothelial cell injury or cycles of endo-in the one-year renal allograft survival to 80 to 90% [1, 2].
thelial cell injury.Unfortunately, the average longevity of an allograft has
In this investigation, we have focused on the othernot shown a comparable improvement, remaining at
major structure in the tubulointerstitial arena, the tubu-eight to nine years [1, 2]. Chronic injury to vascular and
lar epithelium, and specifically its basement membrane.nephron elements, known as chronic rejection (CR), is
We sought to identify a morphologic parameter thatthe most commonly implicated cause of allograft failure
could account for the development of TA and IF in theaffecting 25% of grafts. CR is characterized by a triad
absence of arterial injury and thus explain the associationof histologic changes: arterial occlusive fibrointimal scle-
between AR and subsequent CR/CAN. We observedrosis, tubular atrophy, and interstitial fibrosis [3–5]. Al-
disruptions of the TBM in type I AR spatially related tothough each in isolation is nonspecific, when collectively
regions of active tubulitis. These interruptions in silveridentified, they are regarded as sufficient to support a
staining appear to represent the disappearance of some
rejection-related etiology, namely CR. However, chronic or all TBM components based on the loss of silver stain-
alterations of arterial and nephron components may have ing and loss of laminin staining. Multiple tubular profiles
other etiologies such as donor-related disease, cyclo- demonstrate injury in the most severely inflamed foci.
sporine toxicity, and recipient hypertension. This led to Since they are likely derived from a single nephron or
the introduction of the term chronic allograft nephropa- small number of nephrons, the tubular segment of an
thy (CAN) for cases in which the diagnostic large artery individual nephron may suffer multiple foci of tubular
occlusive lesions are absent [4]. damage. The threshold for this becoming irreversible is
The conventional view is that CR has a vascular etiol- not known, but may be related to the number lytic foci
ogy, because in failed allografts there is severe vascular per nephron or possibly the circumferential nature of
some foci.occlusion associated with variable T-cell and macro-
Fig. 6. A PAS/cytokeratin 7 stain shows epithelial cells within the interstitium.
Fig. 7. A PAS/cytokeratin 7 stain shows a slender cord of epithelial cells without a PAS-stained TBM within the interstitium but attached to the
adjacent tubule.
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Fig. 9. (A) Total TBM breaks at initial biopsy compared with final
creatinine (N 5 7 in each group, P , 0.03). (B) Total TBM breaks at
initial biopsy compared with tubular atrophy on final biopsy (N 5 7 in
each group, P , 0.04).
There are multiple cellular candidates in AR with
TBM lytic capability; likely, several are active in the
rejection event that culminates in the lytic injury we
are investigating. T cells produce granzyme A and B,
Fig. 8. A PAS/laminin immunoperoxidase stain shows focal loss of
molecules that have cytolytic effects on tubular cellslaminin (arrow) in an area of tubulitis.
[33–35]. Tubular cells themselves contain matrix-degrad-
ing proteolytic enzymes, which can be liberated and acti-
vated during cell injury. The most abundant proteolytic
Table 3. Tubular basement membrane (TBM) breaks correlate with enzyme is meprin, which has been shown to produceacute rejection and allograft outcome
lytic TBM injury in the ischemia reperfusion model of
Initial
Final ATN [36, 37]. Inflammatory cells represent another
TBM t 1 i source of lytic enzymes. T cells produce macrophage-
breaks score Creatinine Creatinine Atrophy inhibitory factor responsible for the recruitment and re-
,10 2.660.6 1.760.1 1.960.3 1062.4 tention of macrophages [38]. T-cell–derived granzymes
.10 4.960.5 2.260.1 6.361.7 39.5611.2
A and B can activate macrophage proteases, providingP value ,0.02 ,0.01 ,0.03 ,0.04
an additional source for TBM and matrix dissolution
[33–35]. As shown by the PAS/IP stains of this study,
macrophages are spatially related to the TBM in rejec-
tion events, in a location where TBM lysis could occur.Tubular basement membrane disruptions have been
Recent studies support a significant role for macrophagesobserved by others in several forms of acute tubular
in both allograft dysfunction and CAN. It has been dem-injury, including acute interstitial rejection, acute tubular
onstrated that macrophage activation and the macro-necrosis, and drug-related acute interstitial nephritis
phage index correlate with the clinical versus subclinical[27–32]. The TBM disruptions in AR were first described
AR and predict chronic allograft nephropathy [39, 40].in studies of interstitial extravagation of Tamm-Horsfall
Current immunosuppression protocols for AR, particu-protein by Howie and Brewer and by Cohen et al [31, 32].
larly monoclonal antibody therapy, do not directly targetIn contrast to those studies, we did not observe PAS-
infiltrating macrophages in which effects may linger be-positive material suggestive of Tamm-Horsfall protein
yond the lymphoid cell component.in our cases. The ultrastructural studies of AR by Na-
The observation that tubular epithelial cells herniatedasdy et al demonstrated gaps, ruptures, and segments
into the interstitium and may become completely sepa-of TBM dissolution related to tubular inflammation iden-
tical to the lesions we have described [27]. rated from all tubular connection in AR is an original
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observation not previously reported in AR. The viability tion. The term chronic interstitial rejection may, there-
fore, be appropriate.and longevity of the herniated epithelial cells are not
known. However, viable tubular epithelial cells have
Reprint requests to Stephen M. Bonsib, M.D., Department of Pathol-
been recovered from the urine in ATN [41]. It is plausible ogy, Medical College of Georgia, Augusta, Georgia 30912, USA.
that tubular cells may similarly survive for periods of
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